Brief: Accuray Receives FDA Clearance For Vitalhold On The Radixact System Breast Cancer Treatment Option Will Also Be Available In The EU Market

Accuray Incorporated

10/08/2023 01:16

Aug 9 (Reuters) - Accuray Inc  ARAY.O :
    * ACCURAY RECEIVES FDA CLEARANCE FOR VITALHOLD™ ON THE
RADIXACT®
SYSTEM; BREAST CANCER TREATMENT OPTION WILL ALSO BE AVAILABLE IN
THE EU MARKET

Source text for Eikon:  ID:nPn1ghl7La 
Further company coverage:  ARAY.O 

 ((Reuters.Briefs@thomsonreuters.com;))